Literature DB >> 7190047

Progesterone, fluid, and electrolytes in premenstrual syndrome.

P M O'Brien, C Selby, E M Symonds.   

Abstract

Changes in mood, plasma progesterone concentration, urinary volume, sodium excretion, sodium:potassium ratio, and body weight during the menstrual cycle were determined in 18 women with premenstrual syndrome and 10 symptomless (control group) women. Plasma progesterone concentration was higher in the women with symptoms during the postovulatory phase of the cycle, and the peak progesterone concentration appeared earlier. The changes in progesterone concentration were accompanied by a natriuresis and diuresis that fell towards preovulatory values in the premenstrual phase. Sodium retention was not confined to any definite period. Mood symptoms occurred after the changes in progesterone and electrolyte concentrations. Progesterone deficiency is probably not the cause of premenstrual syndrome. Thus treatment with progesterone is probably illogical unless a deficiency is detected. Treatment should be aimed at preventing the natriuretic effect of progesterone in the postovulatory phase and the sodium-retaining and water-retaining effects of aldosterone in the premenstrual phase.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7190047      PMCID: PMC1601325          DOI: 10.1136/bmj.280.6224.1161

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  8 in total

Review 1.  Premenstrual tension.

Authors:  C M Tonks
Journal:  Br J Psychiatry       Date:  1975       Impact factor: 9.319

2.  Inhibition of the sodium-retaining influence of aldosterone by progesterone.

Authors:  R L LANDAU; K LUGIBIHL
Journal:  J Clin Endocrinol Metab       Date:  1958-11       Impact factor: 5.958

3.  The menstrual cycle and mood disturbances.

Authors:  S L Smith
Journal:  Clin Obstet Gynecol       Date:  1976-06       Impact factor: 2.190

4.  Bromocriptine and premenstrual syndrome: controlled study.

Authors:  K Ghose; A Coppen
Journal:  Br Med J       Date:  1977-01-15

5.  Treatment of premenstrual syndrome by spironolactone.

Authors:  P M O'Brien; D Craven; C Selby; E M Symonds
Journal:  Br J Obstet Gynaecol       Date:  1979-02

6.  A radioimmunoassay for plasma progesterone.

Authors:  S Furuyama; C A Nugent
Journal:  Steroids       Date:  1971-06       Impact factor: 2.668

7.  Correlation of symptoms in pre-menstrual tension to oestrogen and progesterone concentrations in blood plasma. A preliminary study.

Authors:  T Bäckström; B Mattsson
Journal:  Neuropsychobiology       Date:  1975       Impact factor: 2.328

8.  Premenstrual syndrome: a double-blind controlled trial of progesterone and placebo.

Authors:  G A Sampson
Journal:  Br J Psychiatry       Date:  1979-09       Impact factor: 9.319

  8 in total
  6 in total

1.  Cutaneous postural vasoconstriction is modified by exogenous but not endogenous female hormones in young women.

Authors:  Gemma D Bishop; Margaret D Brown
Journal:  Clin Auton Res       Date:  2007-01-30       Impact factor: 4.435

2.  Premenstrual syndrome as a western culture-specific disorder.

Authors:  T M Johnson
Journal:  Cult Med Psychiatry       Date:  1987-09

Review 3.  Progesterone for premenstrual syndrome.

Authors:  Olive Ford; Anne Lethaby; Helen Roberts; Ben Willem J Mol
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

Review 4.  The premenstrual syndrome: a review of the present status of therapy.

Authors:  P M O'Brien
Journal:  Drugs       Date:  1982-08       Impact factor: 9.546

5.  Investigation of the efficacy of progesterone pessaries in the relief of symptoms of premenstrual syndrome. progesterone Study Group.

Authors:  P J Magill
Journal:  Br J Gen Pract       Date:  1995-11       Impact factor: 5.386

6.  Calcium supplementation in premenstrual syndrome: a randomized crossover trial.

Authors:  S Thys-Jacobs; S Ceccarelli; A Bierman; H Weisman; M A Cohen; J Alvir
Journal:  J Gen Intern Med       Date:  1989 May-Jun       Impact factor: 5.128

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.